Factors influencing the efficacy of nebulized colistimethate sodium in the treatment of severe lung infection caused by carbapenem-resistant gram-negative bacteria

We confirmed the clinical benefits of a nebulized CMS-based regimen for treating severe pneumonia. Several influential factors were identified, which may help optimize the clinical use of nebulized CMS.